The DCGI had earlier granted permission to Biological E Limited to conduct phase 2/3 clinical trials on children aged between 5 and 18 years.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.